A new method for predicting SIRS after percutaneous transhepatic gallbladder drainage.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 Dec 2023
Historique:
received: 18 06 2023
accepted: 01 12 2023
medline: 11 12 2023
pubmed: 7 12 2023
entrez: 6 12 2023
Statut: epublish

Résumé

The occurrence of systemic inflammatory response after percutaneous transhepatic gallbladder drainage brings great risks to patients and is one of the challenges faced by clinicians. Therefore, it is of great significance to find a suitable prediction method for clinicians to intervene early and reduce the transformation of serious complications. Easy-to-obtain and objectively measured clinical features were screened, and logistic regression was used to construct a prediction model. The predictive ability of the model was evaluated by using the receiver operating characteristic curve and the decision curve in the validation set and the training set, respectively. Nine clinical features (CRP, Fever, DBIL, Obstruction, Bile properties, PCT, Length, Width, and Volume factor) were used to construct the prediction model, and the validation results showed that the prediction model had good performance in the training set (AUC = 0.83) and the validation set (AUC = 0.81). The decision curve also showed that the predictive ability of the model incorporating nine clinical features is better than that of a single clinical feature. The model we constructed can accurately predict the occurrence of SIRS, which can guide clinicians to take treatment measures and avoid the deterioration of complications.

Identifiants

pubmed: 38057383
doi: 10.1038/s41598-023-48908-6
pii: 10.1038/s41598-023-48908-6
pmc: PMC10700562
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21523

Subventions

Organisme : Xuzhou Science and Technology Bureau
ID : KC20124

Informations de copyright

© 2023. The Author(s).

Références

Indian J Radiol Imaging. 2018 Jan-Mar;28(1):49-54
pubmed: 29692527
Rev Esp Enferm Dig. 2021 Jan;113(1):41-44
pubmed: 33054305
Surg Laparosc Endosc Percutan Tech. 2007 Feb;17(1):14-8
pubmed: 17318047
Ann Surg. 1985 Jul;202(1):59-63
pubmed: 4015212
J Am Coll Surg. 2021 Feb;232(2):195-201
pubmed: 33010429
AJR Am J Roentgenol. 2018 May;210(5):1164-1171
pubmed: 29547060
Evid Based Complement Alternat Med. 2022 Aug 29;2022:5045869
pubmed: 36072405
Am J Surg. 1983 Dec;146(6):719-22
pubmed: 6650754
Surg Endosc. 2017 Nov;31(11):4568-4575
pubmed: 28409378
Medicina (Kaunas). 2021 Mar 02;57(3):
pubmed: 33801408
Gastroenterol Clin North Am. 2010 Jun;39(2):157-69, vii
pubmed: 20478480
Br J Surg. 2004 Jun;91(6):734-8
pubmed: 15164444
Front Immunol. 2020 Aug 25;11:1918
pubmed: 32983116
Microbes Infect. 2006 Apr;8(5):1382-9
pubmed: 16679040
J Inflamm Res. 2022 May 10;15:2901-2910
pubmed: 35602663
J Hepatobiliary Pancreat Surg. 2007;14(1):15-26
pubmed: 17252293
Best Pract Res Clin Gastroenterol. 2006;20(6):981-96
pubmed: 17127183
BMC Gastroenterol. 2022 Nov 28;22(1):491
pubmed: 36437447

Auteurs

Xuanfeng Zhang (X)

Center of Hepatobiliary Pancreatic Disease, XuZhou Central Hospital, No.199 Jiefang South Road, Xuzhou, Jiangsu, People's Republic of China.

Lulu Yang (L)

Department of Radiology, XuZhou Central Hospital, Xuzhou, Jiangsu, People's Republic of China.

Long Cui (L)

Center of Hepatobiliary Pancreatic Disease, XuZhou Central Hospital, No.199 Jiefang South Road, Xuzhou, Jiangsu, People's Republic of China.

Huansong Li (H)

Center of Hepatobiliary Pancreatic Disease, XuZhou Central Hospital, No.199 Jiefang South Road, Xuzhou, Jiangsu, People's Republic of China. xzhuansong@sina.com.

Xiaochuan Wang (X)

Center of Hepatobiliary Pancreatic Disease, XuZhou Central Hospital, No.199 Jiefang South Road, Xuzhou, Jiangsu, People's Republic of China. xchuanwang@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH